Cargando…

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance

Herceptin (trastuzumab) is a recombinant, humanized, monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) and is used in the treatment of HER2-positive breast and gastric cancers. However, it carries a risk of cardiotoxicity, manifesting as left ventricular (LV) systo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jin, Liu, Boyang, Hothi, Sandeep S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898877/ https://www.ncbi.nlm.nih.gov/pubmed/35265371 http://dx.doi.org/10.1155/2022/1910841

Ejemplares similares

Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy
por: Lau, Clement, et al.
Publicado: (2023)

Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014)

Valvular Cardiomyopathy: The Value of Cardiovascular Magnetic Resonance Imaging
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Assessment of acute radiation therapy-related cardiotoxicity by cardiovascular magnetic resonance
por: Traber, Julius, et al.
Publicado: (2016)

Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
por: Smith, Gillian, et al.
Publicado: (2009)

Cardiovascular Magnetic Resonance Imaging in the Early Detection of Cardiotoxicity Induced by Cancer Therapies
por: Wei, Xiaoting, et al.
Publicado: (2022)

The role of Herceptin in early breast cancer
por: Subramanian, Ashok, et al.
Publicado: (2008)

Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability
por: Wilkinson, Emma L., et al.
Publicado: (2016)

Cardiovascular Magnetic Resonance in Early Detection of Radiation Associated Cardiotoxicity With Chest Radiation
por: Vallabhaneni, Srilakshmi, et al.
Publicado: (2022)

Psoriasis Induced by Trastuzumab (Herceptin®)
por: Kim, Dae Hun, et al.
Publicado: (2013)

Mild hyperthermia influence on Herceptin(®) properties
por: Escoffre, Jean-Michel, et al.
Publicado: (2015)

Nicorandil Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats, as Evaluated by 7 T Cardiovascular Magnetic Resonance Imaging
por: Wan, Yixuan, et al.
Publicado: (2021)

Herceptin in clinical use - early 2000
por: Vogel, CL
Publicado: (2000)

Comprehensive cardiovascular assessment of children with chronic kidney disease using exercise cardiac magnetic resonance imaging
por: Cheang, Mun, et al.
Publicado: (2016)

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin(®))
por: Hurst, Susan, et al.
Publicado: (2014)

The cardiovascular phenotype of childhood hypertension: a cardiac magnetic resonance study
por: Cheang, Mun H., et al.
Publicado: (2019)

Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes
por: Park, Heae Surng, et al.
Publicado: (2021)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
por: Lau, Clement, et al.
Publicado: (2022)

Transgenic models are predictive: the herceptin and flavopiridol experience
por: Schmidt, E
Publicado: (2003)

Herceptin clinical trials: past, present and future
por: Vogel, CL
Publicado: (2001)

Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations
por: Hundley, W Gregory, et al.
Publicado: (2009)

Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
por: Miles, David W
Publicado: (2001)

Ultrasound-triggered herceptin liposomes for breast cancer therapy
por: Elamir, Amal, et al.
Publicado: (2021)

Cardiac magnetic resonance characteristics of acute anthracycline-induced cardiotoxicity
por: Toro-Salazar, Olga H, et al.
Publicado: (2016)

ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer
por: Gao, Xiang, et al.
Publicado: (2020)

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin
por: De Lorenzo, C, et al.
Publicado: (2007)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
por: Chung, Caroline, et al.
Publicado: (2009)

Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance
por: Schwitter, Juerg, et al.
Publicado: (2011)

Assessing exercise cardiac reserve using real-time cardiovascular magnetic resonance
por: Le, Thu-Thao, et al.
Publicado: (2017)

Cardiovascular Magnetic Resonance in Myocarditis
por: Polte, Christian L., et al.
Publicado: (2022)

Cardiovascular magnetic resonance artefacts
por: Ferreira, Pedro F, et al.
Publicado: (2013)

Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)
por: Ordovas, Karen G., et al.
Publicado: (2021)

Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2 cells
por: Sun, Lei, et al.
Publicado: (2022)

Role of Cardiovascular Magnetic Resonance to Assess Cardiovascular Inflammation
por: Filomena, Domenico, et al.
Publicado: (2022)

Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance
por: Chan, KM John, et al.
Publicado: (2008)

Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2017)

Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance
por: Ferreira, Vanessa M., et al.
Publicado: (2023)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_06s2ifpccmpd4lmo5l2rtje4gs